Liza Villaruz, Md

This study tested whether a combination of two immunotherapy drugs, tiragolumab and atezolizumab, could help control non-small cell lung cancer that had spread to the brain. It was for patients whose brain tumors were not yet causing symptoms and had not been treated. The main go…